Immunohistochemistry (IHC) 8 Following transcardial perfusion with saline then fixative, brains were removed, post fixed in 9 10% formalin, pH 7.0, for 4h and then submerged overnight in 30% sucrose in DEPC-treated 10 phosphate-buffered saline (DEPC-PBS). Brains were cut on a freezing microtome at 25 m (1:6) and 11 stored in an antifreeze solution containing 30% ethylene glycol and 20% glycerol in DEPC-PBS at -12
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Chromagenic and fluorescent IHC was modified from previous studies (1-4). Each step was 14 preceded by PBS rinses. The sections were pre-treated with 0.3% hydrogen peroxide (Sigma) diluted 15 in PBS for 30 minutes followed by a blocking step with 3% normal donkey serum (Equitech-Bio, 16
Kerrville, TX) diluted in PBS with 0.25% Triton X-100 (PBT) for 1 hour. The tissue was incubated in 17 rabbit primary antiserum for Fos (Calbiochem, La Jolla, CA; 1:10,000) in 0.3% normal donkey serum 18 and PBT-azide (0.02% sodium azide in PBT) overnight at room temperature with gentle agitation. 19
Next, the sections were incubated in biotinylated donkey anti-rabbit immunoglobulin G (Jackson 20
ImmunoResearch, West Grove, PA; 1:1,000) in 0.3% fresh donkey serum and PBT for 1 hour at room 21 temperature, and then in avidin-biotin complex (ABC; Vector Elite kit; Vector laboratories, 22
Burlinghame, CA; 1:500 in PBS) for 1 hour at room temperature. After rinsing, the sections were 23 incubated in 0.04% 3,3'-diaminobenzidine tetrahydrochloride (DAB; Sigma) and 0.01% hydrogen 24 peroxide in PBS. The reaction was terminated after 5-7 minutes with successive rinses in PBS. The 25 sections were mounted onto polysine slides, air-dried overnight, dehydrated in ascending 26 concetrations of ethanol, cleared in xylenes and cover-slipped with mounting medium (Micromount, 27
Surgipath, Peterborough, UK). ectorhinal cortex (Ect; levels from bregma -3.24, −3.84, −4.44, −5.04, -5.64 ). We also examined the 51 primary somatosensory cortex (S1; levels from bregma 1.80, 0.96, 0.36, -0.24, -0.84) as a control 52 cortical area adjacent to the cingulate cortex. All bregma levels were assessed using the rat brain atlas 53 of Paxinos and Watson (5 th edition). Immuno-positive cells for c-fos were counted across the entirety 54 of the brain slice and counts for the different bregma levels were summated for each animal, whichwere then averaged across all the animals in each respective group. This gave a representative 'total' 56 c-fos count for each treatment which was used to produce figures and for statistical comparison. 57 AH treated brains processed for triple IHC for FOS-IR, the neuronal marker NeuN and the glial 58 marker GFAP were assessed qualitatively given the majority of FOS-IR positive cells were co-59 expressed with NeuN, not GFAP. 60
